PURACAP PHARMACEUTICAL Trademark
Trademark Overview
On Tuesday, October 18, 2022, a trademark application was filed for PURACAP PHARMACEUTICAL with the United States Patent and Trademark Office. The USPTO has given the PURACAP PHARMACEUTICAL trademark a serial number of 97636942. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, April 24, 2025. This trademark is owned by PuraCap Pharmaceutical LLC. The PURACAP PHARMACEUTICAL trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceuticals for use in treatment of seizures, hypertension, cardiovascular disease, disease of the endocrine system, gastroenterological disease, hematological disease, infectious disease, disease of the immune system, musculoskeletal disease, kidney disease, disease of the nervous system, gynecological disease, cancer, diseases of the eye, ear, nose and throat, mental illness, rheumatological disease, bone disease, skin wounds, contact dermatitis, headaches, migraine headaches, muscle pain, inflammation, and for use in dental, cosmetic, maxillofacial, and plastic surgery, all available as tablets, capsules, softgels, liquids, creams, and powders
General Information
| Serial Number | 97636942 |
| Word Mark | PURACAP PHARMACEUTICAL |
| Filing Date | Tuesday, October 18, 2022 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Thursday, April 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 12, 2023 |
Trademark Statements
| Description of Mark | The mark consists of the word "PuraCap" over the word "PHARMACEUTICAL" and surrounded by an elliptical shape with its lower right-quadrant omitted. |
| Goods and Services | pharmaceuticals for use in treatment of seizures, hypertension, cardiovascular disease, disease of the endocrine system, gastroenterological disease, hematological disease, infectious disease, disease of the immune system, musculoskeletal disease, kidney disease, disease of the nervous system, gynecological disease, cancer, diseases of the eye, ear, nose and throat, mental illness, rheumatological disease, bone disease, skin wounds, contact dermatitis, headaches, migraine headaches, muscle pain, inflammation, and for use in dental, cosmetic, maxillofacial, and plastic surgery, all available as tablets, capsules, softgels, liquids, creams, and powders |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | " PHARMACEUTICAL" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 2, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | PuraCap Pharmaceutical LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Iselin, NJ 08830 |
| Party Name | PuraCap Pharmaceutical LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Iselin, NJ 08830 |
Trademark Events
| Event Date | Event Description |
| Friday, August 4, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, October 21, 2022 | NEW APPLICATION ENTERED |
| Wednesday, November 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 4, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, August 1, 2023 | ASSIGNED TO EXAMINER |
| Friday, August 4, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, August 4, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, August 4, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 7, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 23, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 12, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 30, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, April 30, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, April 30, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, September 12, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 7, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, May 1, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 30, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 30, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 30, 2024 | SOU EXTENSION 2 GRANTED |
| Wednesday, October 30, 2024 | SOU EXTENSION 2 FILED |
| Thursday, April 24, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, April 24, 2025 | SOU EXTENSION 3 FILED |
| Friday, April 25, 2025 | SOU EXTENSION 3 GRANTED |
| Friday, April 25, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
